Tumor necrosis factor, cachexin TNF-α cytokine NFKB

Introduction

Tumor necrosis factor-alpha (TNF-α) is a critical pro-inflammatory cytokine in the skin. Its production is rapidly upregulated in response to ultraviolet B (UVB) radiation by keratinocytes (KCs) and, to a lesser extent, by dermal fibroblasts (FBs). TNF-α plays a central role in initiating the inflammatory cascade, which is essential for both normal skin responses and pathological conditions such as cutaneous lupus erythematosus (CLE).

The molecular pathways underlying TNF-α induction involve specific transcription factors and gene regulatory elements, as well as synergistic interactions with other cytokines, including interleukin-1 alpha (IL-1α). Understanding these mechanisms provides insight into skin inflammation, UV-induced damage, and potential therapeutic targets.

TNF-α Effects in Skin

TNF-α has multiple pro-inflammatory effects in the skin:

• Induction of adhesion molecules and chemokines: TNF-α promotes the expression of VCAM-1, ICAM-1, and selectins, facilitating leukocyte attachment, rolling, emigration, and chemotaxis into the skin.

• Activation of inducible nitric oxide synthase (iNOS): UVB stimulates iNOS in dermal endothelial cells, contributing to inflammation through a TNF-α-dependent pathway.

• Apoptosis: TNF-α is involved in keratinocyte apoptosis, a key step in forming sunburn cells.

This network of actions establishes a positive feedback loop: infiltrating immune cells secrete additional cytokines that further upregulate TNF-α and downstream inflammatory mediators.

TNF-α Production by Keratinocytes and Fibroblasts

UVB irradiation stimulates TNF-α expression at both the mRNA and protein levels in keratinocytes and fibroblasts. Key points include:

• Synergistic induction: IL-1α enhances TNF-α production, particularly in UVB-irradiated keratinocytes. Fibroblasts produce minimal TNF-α without IL-1α.

• Timing: TNF-α protein is detectable 3–4 hours post UVB exposure in the presence of IL-1α, peaking around 24 hours.

• Wavelength specificity: UVB (290–320 nm) triggers TNF-α induction, whereas UVA (320–400 nm) does not.

This illustrates a finely tuned skin response, where cytokine context and radiation wavelength determine the magnitude of TNF-α production.

Molecular Mechanisms of UVB-Induced TNF-α

The TNF-α gene, located on chromosome 6, is transcriptionally activated by UVB via specific regulatory elements:

• Proximal promoter region: The 109 bp upstream of the transcription start site contains an AP-1 binding site and a putative NF-κB site critical for UVB responsiveness.

• AP-1 activation: UVB exposure phosphorylates c-Jun via c-Jun N-terminal kinase (JNK), enhancing AP-1 activity and TNF-α transcription.

• Inhibition studies: Blocking AP-1 activity with SP600125 suppresses TNF-α induction, confirming AP-1’s central role.

Interestingly, NF-κB elements are not required for UVB-induced TNF-α transcription, highlighting a UV-specific signaling pathway distinct from typical inflammatory stimuli like LPS.

TNF-α Promoter Polymorphisms

Genetic variations in the TNF-α promoter influence cytokine expression and disease susceptibility:

• The -308A polymorphism is linked to subacute cutaneous lupus erythematosus (SCLE) and may modulate transcriptional responses to UVB.

• Effects of polymorphisms are context-dependent, influenced by cell type, promoter construct, and stimulus.

Such variations highlight the interplay between genetics and environmental triggers in skin inflammation.

Cytokine Interactions and Chemokine Regulation

Cytokines released by skin-resident or infiltrating immune cells can amplify TNF-α production:

• IL-1α and TNF-α synergy

  Chemokine specificity: UVB with TNF-α and IL-1α induces CCL20 and CXCL8, whereas IFN-γ promotes CCL5 and CCL22 production.

This cytokine network ensures precise regulation of inflammatory cell recruitment in response to UV damage.

Molecular Sensors of UV in Keratinocytes

Keratinocytes possess specialized transcriptional machinery to sense UV radiation:

• AP-1: Major transcription factor mediating TNF-α upregulation after UVB exposure.

• Crosstalk with NF-κB and C/EBP: While NF-κB is less critical for UVB response, it participates in overall gene regulation.

• UVB-specific signaling: Activation of JNK leads to phosphorylation of c-Jun and increased AP-1 activity, triggering TNF-α transcription.

These molecular sensors enable keratinocytes to respond rapidly to environmental stress while coordinating with immune signals.

Therapeutic Implications: TNF-α Suppression

Blocking TNF-α in skin diseases like lupus is complex:

• Anti-TNF-α therapies can inadvertently increase interferon-regulated gene expression, sometimes exacerbating skin lesions.

• TNF-α also regulates B cell differentiation, indicating its role extends beyond local inflammation.

Careful modulation of TNF-α is thus essential to balance anti-inflammatory benefits with potential immune dysregulation.

Conclusion

TNF-α is a central mediator of skin inflammation, responding to UVB and interacting cytokines through well-defined transcriptional mechanisms. AP-1 activation, synergistic effects with IL-1α, and promoter-specific polymorphisms shape TNF-α production in keratinocytes and fibroblasts. Understanding these pathways provides insight into UV-induced skin damage, autoimmune skin diseases, and potential therapeutic strategies.